Author

John M. Dye

United States Army Medical Research Institute of Infectious DiseasesORCID 0000-0002-0883-5016Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

Andrew S. HerbertiD· 2 shared Jason S. McLellaniD· 2 shared Russell R. BakkeniD· 2 shared Abhinay GontuiD· 1 shared Aditi AgrawaliD· 1 shared Akaash Kumar MishraiD· 1 shared Albert WangiD· 1 shared Amrita OjhaiD· 1 shared

Activity by Year

2021-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Andrew S. HerbertORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

MicrobiologyNature CommunicationsPeer-reviewedJul 10, 2025

PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2

Marwah Karim, Manjari Mishra, Chieh‐Wen Lo…·Shirit Einav

RMC-113 inhibits PIP4K2C and PIKfyve, reversing SARS-CoV-2-induced autophagic flux impairment and showing antiviral effects.

19 citationstop 1%

humanorganoid / primary culture

𝕏 PostBluesky

ImmunologybioRxivPreprintJan 29, 2025

A Multivalent Pan-Ebolavirus Nanoparticle Vaccine Provides Protection in Rodents from Lethal Infection by Adapted Zaire and Sudan Viruses

Natalie Brunette, Connor Weidle, Samuel P. Wrenn…·Lance J. Stewart

This study develops a multivalent nanoparticle vaccine against EBOV and SUDV, showing protection in rodents from lethal infection.

4 citations

mouserat

𝕏 PostBluesky

ImmunologyCell ReportsPeer-reviewedJul 1, 2024

Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38

Olivia S. Shin, Stephanie R. Monticelli, Christy K. Hjorth…·Jason S. McLellan

The paper identifies non-neutralizing antibodies from CCHFV survivors that target multiple regions on GP38, showing protective efficacy in rodent models.

21 citationstop 2%

humanproteomics

𝕏 PostBluesky

Synthetic BiologybioRxivPreprintApr 7, 2021

Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modality

Jule Goike, Ching‐Lin Hsieh, Andrew P. Horton…·Jimmy Gollihar

The paper identifies SARS-CoV-2 neutralizing antibodies from convalescent patients and describes a novel quaternary binding mechanism using high-throughput methods.

11 citations

humanproteomics

𝕏 PostBluesky